CancerCare Manitoba

InstitutionResearch output, impact & collaborations

CancerCare Manitoba is a research organisation in Winnipeg, CA. OpenAlex records 4,289 works and 365,993 citations for it. 767 researchers list it as their most recent affiliation.

4,289

Works

365,993

Citations

767

Researchers

67.2

Avg h-index

IDs:ROR OpenAlex Wikidata

How has CancerCare Manitoba's publication output changed over time?

ScholarIQpublication output · 1997–2019

Output grew0% over the shown period — from 1 works in 1997 to 1 in 2019.

19972005200720102012201620182019

What are the most-cited papers on CancerCare Manitoba?

ScholarIQmost cited works

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

METABRIC Group, Christina Curtis, Sohrab P. Shah, Suet‐Feung Chin, Gulisa Turashvili, Oscar M. Rueda, Mark Dunning, Doug Speed, Andy G. Lynch, Shamith Samarajiwa, Yinyin Yuan, Stefan Gräf, Gavin Ha, Gholamreza Haffari, Ali Bashashati, Roslin Russell, Steven McKinney, Anita Langerød, Andrew R. Green, Elena Provenzano, Gordon Wishart, Sarah E. Pinder, Peter H. Watson, Florian Markowetz, Leigh C. Murphy, Ian O. Ellis, Arnie Purushotham, Anne‐Lise Børresen‐Dale, James D. Brenton, Simon Tavaré, Carlos Caldas, Samuel Aparício

Nature. 20126,440 CitationsOPEN ACCESS

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

Martine Piccart, Marion Procter, Brian Leyland‐Jones, Aron Goldhirsch, Michael Untch, Ian Smith, Luca Gianni, José Baselga, Richard H. Bell, Christian Jackisch, David Cameron, Mitch Dowsett, Carlos H. Barrios, Günther Steger, Chiun‐Sheng Huang, Michael Andersson, Moshe Inbar, Mikhail Lichinitser, István Láng, Ulrike Nitz, Hiroji Iwata, Christoph Thomssen, Caroline Lohrisch, Thomas Suter, Josef Rüschoff, Tamás Sütö, Victoria Greatorex, Carol Ward, Carolyn Straehle, Eleanor McFadden, Mirko Dolci, Richard D. Gelber

New England Journal of Medicine. 20055,111 CitationsOPEN ACCESS

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Mikhail Lichinitser, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger H.T. Koornstra, Leonel F. Hernandez‐Aya, Michele Maio, Alfonsus Johannes Maria van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul Lorigan, Nageatte Ibrahim, Sandrine Marréaud, Alexander C. J. van Akkooi, Stefan Suciu, Caroline Robert

New England Journal of Medicine. 20181,870 CitationsOPEN ACCESS

The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes

Bernard Pereira, Suet‐Feung Chin, Oscar M. Rueda, Hans-Kristian Moen Vollan, Elena Provenzano, Helen Bardwell, Michelle Pugh, Linda Jones, Roslin Russell, Stephen‐John Sammut, Dana W.Y. Tsui, Bin Liu, Sarah‐Jane Dawson, Jean Abraham, Helen Northen, John F. Peden, Abhik Mukherjee, Gulisa Turashvili, Andrew R. Green, Steve McKinney, Arusha Oloumi, Sohrab P. Shah, Nitzan Rosenfeld, Leigh C. Murphy, David Bentley, Ian O. Ellis, Arnie Purushotham, Sarah E. Pinder, Anne‐Lise Børresen‐Dale, Helena Earl, Paul D.P. Pharoah, Mark T. Ross, Samuel Aparício, Carlos Caldas

Nature Communications. 20161,812 CitationsOPEN ACCESS

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

Luca Gianni, W. Eiermann, Semiglazov Vf, Alexey Manikhas, Aňa Lluch, S. Tjulandin, Milvia Zambetti, Federico Vázquez, Mikhail Byakhow, Mikhail Lichinitser, Miguel Ángel Climent, Eva Ciruelos, B. Ojeda, Mauro Mansutti, А. А. Божок, Roberta Baronio, A. Feyereislova, Claire Barton, Pinuccia Valagussa, José Baselga

The Lancet. 20101,270 Citations